Robot that removes cancer tumours without incisions gets $20.5 mil funding

Professor Lawrence Ho Khek Yu

Robot that removes cancer tumours without incisions gets $20.5 mil funding

By: 
Jude Chan
16/03/17, 04:46 pm

SINGAPORE (March 16): Local medical robotics firm EndoMaster announced Thursday that it raised $20.5 million in March – one of the largest sums for Series B funding for medical technology companies in Singapore.

EndoMaster’s robotic-assisted surgical system is able to remove gastro-intestinal cancer tumours without the need for surgical incisions on the body or organ.

According to EndoMaster, gastro-intestinal cancer is diagnosed in over three million people worldwide and causes more than two million deaths every year.

Current treatments to remove gastro-intestinal tumours require incisions on the abdomen and cutting out the affected sections of the stomach, colon or rectum.

A spin-off by Nanyang Technological University (NTU) and National University of Singapore (NUS), EndoMaster’s non-invasive tumour-removal lowers surgery time to less than one hour.

“The EndoMaster system was designed to enable complicated surgeries to be performed using existing openings like the mouth and anus, without requiring additional surgical access points,” says EndoMaster co-founder Louis Phee.

“In the future, we aim to perform more ‘no-hole’ surgeries on other major organs. The cost and medical benefits are apparent,” Phee adds.

EndoMaster says it is targeting the fast-growing global medical robotics market. The market is growing at a compound annual growth rate of 21.1%, and expected to more than double to US$12.8 billion by 2021.

“The new funds will enable EndoMaster to scale up this disruptive innovation, making endoscopic surgery easy, safe, and accessible to many more doctors in this world,” says EndoMaster co-founder Lawrence Ho.

EndoMaster says it is looking to launch its product in Europe in late 2018. It aims to surpass $100 million in revenue within five years of its product launch.

To find out more about the Master and Slave Transluminal Endoscopic Robot (MASTER), which was featured in The Edge Singapore in March 2014, click to read: Medical marvel.

SGX stock falls 2% before midday break on news of potential injunction

SINGAPORE (May 22): Singapore Exchange (SGX) is facing a potential interim injunction on the India equity derivative products it intends to launch in June this year, but maintains that it nonetheless will continue to list the products as planned. To recap, SGX earlier announced its intention to launch three derivative products in June 2018 – SGX India futures, SGX India options and SGX India bank futures – to succeed the derivatives it used to offer on India’s benchmark Nifty 50. See: SGX shares opens near 7% lower on Nifty futures exit news See: Singapore turns India's Nifty in....
Read More >>

Former Malaysian PM Najib questioned by anti-graft agency

PUTRAJAYA (May 22): Former Malaysian Prime Minister Najib Razak was being questioned Tuesday by anti-corruption police about a graft scandal that could lead to criminal charges against him. He was summoned nearly two weeks after the defeat of his long-ruling coalition in national elections, a loss partly due to public anger over alleged corruption at the 1Malaysia Development Berhad (1MDB), the state investment fund that Najib set up. US investigators say Najib's associates stole and laundered US$4.5 billion ($6 billion) from the fund, some of which landed in Najib's bank account. Swa....
Read More >>

China likely to ease up slightly on financial tightening amid credit slowdown: Oxford Economics

SINGAPORE (May 22): China is likely to shift away from tighter financial policies amid a stronger-than-expected credit slowdown since December last year, even as GDP growth remains a key policy objective, according to research firm Oxford Economics. “The government has put ‘boosting domestic demand’ back on the policy agenda while de-emphasising the task of ‘deleveraging’, fuelling speculation that China is shifting away from tighter financial policies,” says lead economist Tianjie He in a report on Tuesday. However, He highlights that policymakers are not expected to make dr....
Read More >>